Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Notice of annual general meeting of Gabriel Holding A/S
-
Copenhagen Infrastructure Partners charges to the top of the UK battery stack
-
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology
-
BitMEX Launches Multi Asset Margining: Simplifying Trading for Derivatives Markets
-
Form 8.3 - Warpaint London Plc
-
Form 8.3 - Renewi Plc
-
Form 8.3 - Learning Technologies Group Plc
-
Alliance Witan PLC - Net Asset Value
-
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
-
Foresight Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Amplify ETFs to Liquidate the Amplify U.S. Alternative Harvest ETF (MJUS)
-
Nayax, the Leader in Seamless Payment and Commerce Solutions, Set to Unveil 'Retail Your Way' at NRF 2025
-
Angitia Biopharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
-
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
-
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
-
Gaxos to Participate in The Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico
-
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
-
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
-
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
GURU Organic Energy Announces Appointment of New Executive Vice President, Sales
-
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
-
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
-
Atsena Therapeutics Initiates Part B of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat X-linked Retinoschisis
-
RAID: Shadow Legends Steps Into the Rabbit Hole with ‘RAID: Alice’s Adventure’ Special Event
-
PortIO Completes Keiretsu Forum MST Due Diligence, Paving the Way for Fast-Track Funding
-
Arch Biopartners Announces Ontario Research Ethics Board Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
-
Lithium Argentina Provides 2024 Production Results, 2025 Guidance and Update on Special Meeting of Shareholders
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
uniQure Announces Pricing of its Public Offering
-
Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
-
RCLCO Ranks Summerlin® and Bridgeland® Among Nation’s Top 10 Best-Selling Master Planned Communities of 2024
-
CommunityAmerica Credit Union Accelerates St. Louis Expansion, Merging with Electro Savings Credit Union
-
CURRENC Debuts SEAMLESS AI Call Centre Solutions
-
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
-
BexBack Offers 100x Leverage, Double Deposit Bonus and $50 Welcome Bonus for New Users—No KYC Required
-
Lithium Ionic: 2024 Year-in-Review, Setting Stage for a Pivotal 2025
-
Microbix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay Markets
-
Lantronix CEO Saleel Awsare Named “IoT Company CEO of the Year” in 2025 IoT Breakthrough Awards Program
-
Volvo Cars Canada named official automotive partner of Canada Snowboard
-
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
-
AI-Driven Crypto research platform SoSoValue raises $15 million Series A to launch the Investible Spot Index Protocol SSI
-
ASDSA Finds Lack of Physician Supervision in Medical Spas
-
Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer
-
Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
-
LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia
-
The Simply Good Foods Company Reports Fiscal First Quarter 2025 Financial Results and Reaffirms Fiscal Year 2025 Outlook
-
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
-
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
-
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
